pseudoporphyria

A drug-induced photodermatosis characterized by skin fragility, erythema, and the appearance of tense bullae, erosions and scarring in the absence of… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Imatinib, a synthetic tyrosine kinase inhibitor, is used as first-line therapy for chronic myeloid leukaemia. Imatinib treatment… (More)
Is this relevant?
2008
2008
Fig. 1. Erosions on the forehead. Fig. 2. Erosions, milia and scarring on the dorsum of the hand. Sir, Porphyria cutanea tarda… (More)
  • figure 1
Is this relevant?
2007
2007
Pseudoporphyria is a bullous photosensitivity, the commonest aetiology being secondary to various ingested medications… (More)
Is this relevant?
2007
2007
Pseudoporphyria is a rare photosensitivity that resembles porphyria cutanea tarda clinically but lacks the biochemical… (More)
Is this relevant?
Review
2005
Review
2005
Pseudoporphyria is an uncommon blistering disorder with clinical and histologic similarities to porphyria cutanea tarda but which… (More)
Is this relevant?
2004
2004
Voriconazole, a second-generation triazole, has recently been approved by the Food and Drug Administration (FDA) to treat… (More)
Is this relevant?
2000
2000
Pseudoporphyria is characterized by erythema, blistering, and scarring on sun-exposed skin. Nonsteroidal antiinflammatory drugs… (More)
Is this relevant?
1999
1999
Bullous dermatoses (BD) are well recognized in patients with end-stage renal disease (ESRD). It is important to distinguish… (More)
Is this relevant?
1994
1994
Pseudoporphyria, a cutaneous disorder characterized by skin fragility, vesiculation, and scarring, has been reported as a side… (More)
Is this relevant?
1989
1989
The clinical details of four fair-skinned women with recurrent blistering and skin fragility are presented. All had considerable… (More)
Is this relevant?